Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program.

@article{Chua2010EvaluationOT,
  title={Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program.},
  author={Terence C Chua and Samantha J Martin and Akshat Saxena and Winston Spencer Liauw and Tristan Dongbo Yan and Jing Zhao and Irene Lok and David L Morris},
  journal={Annals of surgery},
  year={2010},
  volume={251 2},
  pages={323-9}
}
BACKGROUND Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are treatment approaches for peritoneal carcinomatosis that has demonstrated improved survival outcomes with acceptable complication rates. This report aims to measure and describe the survival outcomes and health care cost associated with CRS and HIPEC for peritoneal surface malignancies at a centralized tertiary institution in Australia. METHODS The expenditure of treatment for 136 consecutive… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Peritonectomy and hyperthermic intraperitoneal chemotherapy: cost analysis and sustainability.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology • 2015
View 3 Excerpts

Similar Papers

Loading similar papers…